Rockwell Medical, Inc. (RMTI)
NASDAQ: RMTI · IEX Real-Time Price · USD
1.630
+0.090 (5.84%)
At close: May 2, 2024, 4:00 PM
1.610
-0.020 (-1.23%)
After-hours: May 2, 2024, 4:53 PM EDT

Rockwell Medical Revenue

In the year 2023, Rockwell Medical had annual revenue of $83.61M with 14.84% growth. Revenue in the quarter ending December 31, 2023 was $22.09M with 14.39% year-over-year growth.

Revenue (ttm)
$83.61M
Revenue Growth
+14.84%
P/S Ratio
0.57
Revenue / Employee
$352,793
Employees
237
Market Cap
47.86M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202383.61M10.80M14.84%
Dec 31, 202272.81M10.88M17.57%
Dec 31, 202161.93M-266.00K-0.43%
Dec 31, 202062.20M894.00K1.46%
Dec 31, 201961.30M-2.09M-3.29%
Dec 31, 201863.39M6.09M10.63%
Dec 31, 201757.30M4.02M7.54%
Dec 31, 201653.28M-2.07M-3.73%
Dec 31, 201555.35M1.16M2.14%
Dec 31, 201454.19M1.81M3.45%
Dec 31, 201352.38M2.54M5.09%
Dec 31, 201249.84M876.16K1.79%
Dec 31, 201148.97M-10.59M-17.78%
Dec 31, 201059.55M4.83M8.82%
Dec 31, 200954.73M3.06M5.93%
Dec 31, 200851.67M8.62M20.03%
Dec 31, 200743.05M14.41M50.30%
Dec 31, 200628.64M943.90K3.41%
Dec 31, 200527.69M9.75M54.33%
Dec 31, 200417.94M2.97M19.87%
Dec 31, 200314.97M3.47M30.22%
Dec 31, 200211.50M2.48M27.51%
Dec 31, 20019.02M1.56M20.90%
Dec 31, 20007.46M768.09K11.48%
Dec 31, 19996.69M1.42M26.86%
Dec 31, 19985.27M1.95M58.87%
Dec 31, 19973.32M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cytosorbents 36.35M
Cara Therapeutics 20.97M
DarioHealth 20.35M
Bolt Biotherapeutics 7.88M
Cyclo Therapeutics 1.08M
Revenue Rankings